Nabriva Therapeutics plc (NBRVF)
OTCMKTS: NBRVF · Delayed Price · USD
0.0001
0.00 (0.00%)
Jul 9, 2024, 9:30 AM EDT - Market closed
Nabriva Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 - 2013 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
Cash & Equivalents | 2.18 | 12.41 | 47.66 | 41.36 | 86.02 | 102 | Upgrade
|
Short-Term Investments | - | - | 0.02 | 0.02 | 0.18 | 0.23 | Upgrade
|
Cash & Short-Term Investments | 2.18 | 12.41 | 47.68 | 41.38 | 86.19 | 102.23 | Upgrade
|
Cash Growth | -89.11% | -73.96% | 15.23% | -52.00% | -15.68% | 17.67% | Upgrade
|
Accounts Receivable | 4.44 | 5.95 | 12.21 | 3.79 | 1.53 | 4.26 | Upgrade
|
Other Receivables | - | 0.79 | 0.54 | 0.12 | 1.21 | 1.11 | Upgrade
|
Receivables | 4.44 | 6.74 | 12.75 | 3.91 | 2.74 | 5.37 | Upgrade
|
Inventory | - | 9.68 | 14.51 | 5.82 | 0.68 | - | Upgrade
|
Prepaid Expenses | 3.26 | 2.15 | 5.16 | 5.88 | 1.16 | 1.15 | Upgrade
|
Restricted Cash | 0.07 | 0.12 | 0.18 | 0.23 | 0.39 | - | Upgrade
|
Total Current Assets | 9.95 | 31.1 | 80.27 | 57.22 | 91.17 | 108.75 | Upgrade
|
Property, Plant & Equipment | 0.25 | 0.28 | 0.23 | 0.77 | 2.47 | 1.14 | Upgrade
|
Other Intangible Assets | 0 | 0 | 0.03 | 0.08 | 0.09 | 0.1 | Upgrade
|
Other Long-Term Assets | 0.38 | 0.38 | 0.38 | 0.37 | 0.38 | 0.43 | Upgrade
|
Total Assets | 10.58 | 31.77 | 80.91 | 58.44 | 94.11 | 110.42 | Upgrade
|
Accounts Payable | 14.03 | 5.43 | 4.37 | 2.89 | 4.67 | 3.3 | Upgrade
|
Accrued Expenses | 7.9 | 7.15 | 9.45 | 5.89 | 8.63 | 12.86 | Upgrade
|
Current Portion of Long-Term Debt | 0.2 | 4.83 | 3.77 | 2.04 | - | - | Upgrade
|
Current Unearned Revenue | - | - | 0.37 | 0.75 | - | - | Upgrade
|
Other Current Liabilities | 4.08 | 10.19 | 4.38 | 6.96 | 3.34 | 1.65 | Upgrade
|
Total Current Liabilities | 26.2 | 27.61 | 22.34 | 18.52 | 16.64 | 17.81 | Upgrade
|
Long-Term Debt | 0.34 | 0.39 | 4.27 | 5.69 | 34.5 | 23.72 | Upgrade
|
Other Long-Term Liabilities | 0.35 | 0.48 | 0.95 | 1.09 | 1.7 | 0.26 | Upgrade
|
Total Liabilities | 26.9 | 28.47 | 27.56 | 25.3 | 52.84 | 41.79 | Upgrade
|
Common Stock | 0.03 | 0.03 | 0.02 | 0.21 | 0.1 | 0.67 | Upgrade
|
Additional Paid-In Capital | 657.24 | 656.1 | 648.98 | 579.12 | 517.89 | 461.91 | Upgrade
|
Retained Earnings | -673.62 | -652.86 | -595.68 | -546.23 | -476.74 | -393.98 | Upgrade
|
Comprensive Income & Other | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
Shareholders' Equity | -16.32 | 3.29 | 53.35 | 33.14 | 41.27 | 68.63 | Upgrade
|
Total Liabilities & Equity | 10.58 | 31.77 | 80.91 | 58.44 | 94.11 | 110.42 | Upgrade
|
Total Debt | 0.54 | 5.22 | 8.03 | 7.73 | 34.5 | 23.72 | Upgrade
|
Net Cash (Debt) | 1.64 | 7.19 | 39.65 | 33.65 | 51.69 | 78.51 | Upgrade
|
Net Cash Growth | -87.28% | -81.86% | 17.82% | -34.91% | -34.16% | -9.39% | Upgrade
|
Net Cash Per Share | 0.53 | 2.68 | 22.86 | 65.49 | 174.17 | 386.40 | Upgrade
|
Filing Date Shares Outstanding | 3.23 | 3.2 | 2.42 | 1 | 0.38 | 0.28 | Upgrade
|
Total Common Shares Outstanding | 3.23 | 3.2 | 2.27 | 0.84 | 0.38 | 0.27 | Upgrade
|
Working Capital | -16.25 | 3.5 | 57.93 | 38.69 | 74.53 | 90.95 | Upgrade
|
Book Value Per Share | -5.05 | 1.03 | 23.52 | 39.30 | 109.14 | 256.01 | Upgrade
|
Tangible Book Value | -16.32 | 3.29 | 53.32 | 33.06 | 41.18 | 68.53 | Upgrade
|
Tangible Book Value Per Share | -5.05 | 1.03 | 23.50 | 39.20 | 108.90 | 255.64 | Upgrade
|
Machinery | - | 4.8 | 4.59 | 4.67 | 4.6 | 4.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.